0001209191-20-033993.txt : 20200603
0001209191-20-033993.hdr.sgml : 20200603
20200603162225
ACCESSION NUMBER: 0001209191-20-033993
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200601
FILED AS OF DATE: 20200603
DATE AS OF CHANGE: 20200603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bhatia Sangeeta N.
CENTRAL INDEX KEY: 0001643921
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20940285
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001643921
Bhatia Sangeeta N.
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2020-06-01
4
A
0
1398
0.00
A
6647
D
Common Stock
2020-06-02
4
S
0
50
279.52
D
6597
D
Common Stock
2020-06-02
4
S
0
200
281.20
D
6397
D
Common Stock
2020-06-02
4
S
0
313
282.86
D
6084
D
Common Stock
2020-06-02
4
S
0
289
283.84
D
5795
D
Common Stock
2020-06-02
4
S
0
50
284.62
D
5745
D
Common Stock
2020-06-02
4
S
0
50
285.73
D
5695
D
Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $281.20 (range $281.01 to $281.66).
Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $282.86 (range $282.36 to $283.31).
Open market sales reported on this line occurred at a weighted average price of $283.84 (range $283.47 to $284.23).
/s/ Sabrina Yohai, Attorney-in-Fact
2020-06-03